Bolar is a leading Nigerian pharmaceutical company established in 1984, but started operations in 1986, with a retail pharmacy. Over the years Bolar has represented several multinational companies in marketing and distribution. These include Johnson and Johnson, Astra Zeneca, Pharmacia and Upjohn, Sanofi, and Grunenthal. Bolar is presently focusing on developing own brands based on unique and natural ingredients and products, as well as new molecules which have been shown extensively to provide viable options for disease management and treatment. Bolar has partnered with local and international organizations to gain access to these unique ingredients and molecules. Over the coming years, Bolar will be introducing products in chronic disease areas where present treatments are unsatisfactory or could be improved upon. These include sickle cell, hepatitis, diabetes, cancer, BHP (Benign Prostatic Hyperplasia), Cardiovascular disease (CVD) and arthritis.